HoldsUp

Mark Hyman, MD · 2025-06-25 · Mark Hyman (host), Anurag Singh

Longevity Scientist: Can This Supplement Really Reverse Aging?

48 claims checked against research: 3 contradicted 9 overstated 3 needing context 28 supported 5 unverified

3

Contradicted by research

0:35:54Mark Hyman (host)contradictedmoderate

Conditions including autism, Alzheimer's disease, schizophrenia, bipolar disorder, depression, and diabetes are mitochondrial disorders that respond better to ketogenic diets than to any other current therapy.

"certain diseases like whether it's autism or Alzheimer's or schizophrenia or bipolar disease or depression, diabetes and these are all mitochondrial problems and they all respond extremely well to ketogenic diets. They respond better than any other current therapy." (said at 0:35:54)

The claim that autism, Alzheimer's disease, schizophrenia, bipolar disorder, depression, and diabetes 'respond better [to ketogenic diets] than to any other current therapy' is contradicted by clinical evidence. While ketogenic dietary interventions are being actively researched for metabolic and neuropsychiatric conditions—showing modest effects in depressive symptoms, cognitive outcomes in small trials, or glycemic control—current evidence does not show that ketogenic diets outperform standard first-line therapies (such as antipsychotics, mood stabilizers, psychotherapy, or standard diabetes medications). Systematic reviews consistently find that clinical evidence in psychiatric and neurodevelopmental conditions remains preliminary, heterogeneous, or derived largely from small, uncontrolled studies rather than superiority over established standard-of-care treatments.

0:32:48Anurag Singhcontradictedhigh

Mitochondria are a primary site where a significant amount of cellular protein synthesis occurs.

"what people forget is that mitochondria is where a lot of protein synthesis is actually happening." (said at 0:32:48)

The claim that mitochondria are where "a lot of protein synthesis is actually happening" or a primary site for cellular protein synthesis is contradicted by cellular biology research. Human mitochondrial DNA encodes only 13 proteins (all subunits of the oxidative phosphorylation system), while the vast majority (approximately 99%) of all mitochondrial proteins—and essentially all non-mitochondrial cellular proteins—are transcribed from nuclear DNA and synthesized by cytosolic ribosomes before being imported into the organelle. Thus, mitochondrial translation accounts for only a minute fraction of overall cellular protein synthesis.

1:28:43Mark Hyman (host)contradictedhigh

The brain has the highest density of mitochondria of any organ in the body.

"the brain is, again, has the most density of mitochondria of any organ in the body." (said at 1:28:43)

The claim that the brain has the highest mitochondrial density of any organ in the body is contradicted by standard anatomical and physiological research. The heart (cardiac muscle) has the highest mitochondrial density and content of any tissue or organ in the human body, where mitochondria occupy approximately 35% to 40% of cardiomyocyte volume to support continuous contractile activity. While the brain has high energy demands and rich mitochondrial content, it does not exceed that of cardiac tissue.

9

Overstated

0:20:53Anurag Singhoverstatedmoderate

Sleep disorders can precede and lead to the development of neurodegenerative diseases like Alzheimer's or Parkinson's disease 20 years later.

"And the professor who came to us actually found that these folks actually, all 20 years after sleep issues, they turn into neurodegenerative disorders, so they either get an Alzheimer's or Parkinson's, and the fundamental root cause is mitochondrial imbalance in their brain that triggers these sleep imbalances." (said at 0:20:53)

The claim is overstated. Longitudinal cohort studies demonstrate that specific sleep disorders, most notably isolated rapid eye movement (REM) sleep behavior disorder (iRBD), serve as prodromal manifestations that convert into neurodegenerative alpha-synucleinopathies (such as Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy) over an extended timeframe, with an average interval of ~14 years and a range spanning up to 29 years. However, this high phenoconversion rate applies specifically to REM sleep behavior disorder rather than generic sleep disorders, does not apply to all sleep issues, and represents early manifestations of ongoing neurodegeneration rather than establishing that sleep disturbance itself causes the subsequent diseases.

  • partial: Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially dia… (Sleep medicine 2013) · cited 814x in the literature
    "80.8% (21/26) of patients who were initially diagnosed with iRBD eventually developed parkinsonism/dementia (three of the original 29 patients were lost to follow-up). The distribution of diagnoses was as follows: n=13, Parkinson's disease (PD); n=3, dementia with Lewy bodies (DLB); n=1, dementia (unspecified; profound); n=2, multiple system atrophy (MSA); n=2, clinically diagnosed Alzheimer's Disease (AD) with autopsy-confirmed combined AD plus Lewy body disease pathology. Among the 21 iRBD "converters," the mean age (±SD) of iRBD onset was 57.7±7.7 years; mean age (±SD) of parkinsonism/dementia onset was 71.9±6.6 years; and mean interval (±SD) from iRBD onset to parkinsonism/dementia onset was 14.2±6.2 years (range: 5-29 years)." (abstract, results, passage verified)
    pubmedfull study (doi)
0:33:40Anurag Singhoverstatedmoderate

Eating 15% fewer calories has been shown in multiple randomized trials to have a major impact on boosting mitochondrial health.

"So eating 15% less has—we have seen in multiple randomized trials that has a big impact on boosting mitochondrial health." (said at 0:33:40)

While a 6-month randomized controlled trial of 25% caloric restriction (CALERIE Phase 1) found increases in skeletal muscle mitochondrial DNA content and biogenesis gene expression (PMID 17341128), larger and longer-term trials of sustained ~12–15% caloric restriction (CALERIE Phase 2) did not demonstrate a major boost in functional mitochondrial performance. Specifically, 12 months of caloric restriction produced no significant changes in in vivo muscle maximal ATP synthesis rate or coupling efficiency (PMID 27778643), and 24 months of caloric restriction showed no significant difference compared to control in muscle mitochondrial DNA copy number or mutation frequency (PMID 41886216), despite modulating the transcription of genes involved in mitochondrial biogenesis and quality control pathways (PMID 37823711). Claiming that multiple randomized trials demonstrate a major impact on boosting mitochondrial health overstates the human clinical evidence.

0:35:49Anurag Singhoverstatedhigh

Mitochondria have a preference for utilizing fat as fuel over glucose.

"Their preference for fuel utilization is more fat than glucose." (said at 0:35:49)

The assertion that mitochondria intrinsically prefer utilizing fat over glucose is an oversimplification and overstatement. Mitochondrial substrate utilization is dynamic, highly tissue-specific, and governed by substrate availability, hormonal state, workload, and metabolic flexibility (such as described by the Randle cycle). While certain highly oxidative tissues (such as the adult myocardium and resting skeletal muscle) derive the majority (e.g., 40–70%) of their ATP from fatty acid β-oxidation under normal physiological conditions, other tissues rely predominantly on glucose-derived pyruvate (e.g., brain/neurons, renal medulla, glycolytic muscle fibers) or readily shift preference based on nutritional status (fed vs. fasted state). Mitochondria do not possess a universal, intrinsic preference for fat over glucose across all cell types and conditions.

0:42:34Anurag Singhoverstatedmoderate

In clinical studies on sedentary older adults, oral dosing of 500 mg to 1 g of urolithin A increases PGC-1 alpha and decreases damaged mitochondrial DNA at 1 month, improves peak VO2 at 2 months, and increases muscle strength after 4 months.

"The first studies I did was I started giving, you know, increasing doses of this molecule to older adults who are sedentary, and I found a sweet spot around the 500 milligram to a gram dosing of this molecule where a month in, no big physiological effects, but if I went in and took blood and biopsies, I could see the damaged mitochondria turn and become into healthier mitochondria. There was more PGC-1 alpha, there was less damaged mitochondrial DNA. Two months into supplementation is where I pick up things like physiological changes. So peak VO2 is improved... And then longer term, 4 months up, we start seeing these real long-term benefits that I mentioned about, which is improvement in strength." (said at 0:42:34)

The speaker conflates findings and timelines across multiple distinct clinical trials conducted by their research team. In a 4-week trial in sedentary older adults (500 mg and 1,000 mg/day), urolithin A was found to modulate skeletal muscle mitochondrial gene expression and plasma biomarkers without functional changes. In a subsequent 4-month trial in older adults (65–90 years), supplementation improved muscle endurance at 2 months, but primary endpoints (6-minute walk distance and maximal ATP production) did not show statistically significant differences versus placebo at 4 months. Improvements in peak VO2 and muscle strength (~12%) were actually demonstrated at 4 months in a separate randomized trial of middle-aged adults (40–65 years), rather than at 2 months or exclusively in older adults.

0:47:09Anurag Singhoverstatedlow

Clinical trials of urolithin A across sedentary older adults, overweight individuals, and elite athletes consistently demonstrate reductions in C-reactive protein, interleukin-1 beta, and TNF-alpha alongside improved mitochondrial health.

"The early trials we did, as I mentioned, whether it was the older adults, you know, sitting on their couch potato, not getting to move, or the overweight folks, or even the elite athletes, the hallmarks—whenever we would see improved mitochondrial health, in the background we would always see lowering of C-reactive protein, we would always see lowering of interleukin-1 beta or TNF-alpha." (said at 0:47:09)

Randomized controlled trials evaluating urolithin A in humans (including older adults and trained endurance athletes) have shown preliminary signals of mitochondrial modulation and proteomic downregulation of inflammatory pathways. However, claiming that trials across sedentary older adults, overweight individuals, and elite athletes 'consistently demonstrate' or 'always' show significant reductions in C-reactive protein (CRP), interleukin-1 beta (IL-1β), and TNF-α overstates the published evidence. A systematic review of human trials notes that clinical evidence remains preliminary across small cohorts (n = 236 across five trials), with mitochondrial and inflammatory biomarkers showing heterogeneous, exploratory outcomes rather than established, consistent efficacy.

1:51:47Mark Hyman (host)overstatedlow

Almost everyone taking a statin shows damaged mitochondria on a muscle biopsy, even in the absence of muscle pain or elevated creatine phosphokinase (CPK).

"some of the studies I've seen is even without any muscle pain, even without an abnormal blood test, which you can see damage to the muscle called CPK, that pretty much everybody on a statin, if you do a muscle biopsy, has damaged mitochondria." (said at 1:51:47)

While some small observational studies of muscle biopsies suggest statins can induce subclinical alterations in energy metabolism and slight reductions in mitochondrial oxidative capacity in asymptomatic individuals, claiming that "pretty much everybody" on a statin exhibits damaged mitochondria on muscle biopsy significantly exaggerates the findings. In a study comparing asymptomatic statin users, symptomatic users, and controls, mitochondrial complex activities were significantly reduced only in symptomatic users, while mitochondrial content showed only non-significant trends toward reduction in asymptomatic users. Furthermore, gene expression analysis of skeletal muscle biopsies from asymptomatic statin-treated patients showed that expression of genes responsible for mitochondrial function was unaffected.

1:52:29Anurag Singhoverstatedhigh

GLP-1 receptor agonist medications cause a 20% to 30% loss of muscle mass.

"there's this buzz with the GLP-1 that, you know, with the GLP-1 story, that you lose 20, 30% muscle." (said at 1:52:29)

The claim confuses the composition of total weight lost with the proportion of overall muscle mass lost. In clinical trials and meta-analyses of GLP-1 receptor agonists, lean or muscle mass accounts for approximately 20% to 30% of the total weight lost (a standard proportion seen during calorie restriction and weight reduction). However, patients do not lose 20% to 30% of their total body muscle mass; baseline lean mass decreases by only around 3% to 5% (or ~1.7 to 5.4 kg), and because fat mass decreases much more substantially, lean mass as a proportion of total body weight actually increases.

1:32:40Mark Hyman (host)overstatedlow

Administering a metabolic supplement cocktail including CoQ10, carnitine, creatine, ribose, alpha-lipoic acid, N-acetylcysteine, and B vitamins improves ejection fraction in heart failure patients.

"So when I have heart failure patients, I will give them a mitochondrial cocktail of supplements including CoQ10, carnitine, creatine, ribose, lipoic acid, N-acetylcysteine, the B vitamins, and basically what happens is quite remarkable. They improve their cardiac function by objective metrics, like what we call ejection fraction" (said at 1:32:40)

While individual components of metabolic cardiology regimens—such as coenzyme Q10, L-carnitine, and D-ribose—have been investigated in clinical trials and systematic reviews with reports of modest improvements in left ventricular ejection fraction and functional parameters as adjunctive therapies in heart failure, robust clinical trial evidence demonstrating that this specific multi-ingredient combination cocktail (including creatine, alpha-lipoic acid, N-acetylcysteine, and B vitamins) reliably produces remarkable improvements in cardiac function is lacking. Published literature on this comprehensive cocktail consists primarily of narrative reviews and conceptual frameworks rather than rigorous randomized controlled trials evaluating the full combination.

1:57:54Anurag Singhoverstatedlow

Scientific evidence demonstrates beneficial effects of sauna use on mitochondrial health.

"There's a lot of good evidence in sauna for mitochondria." (said at 1:57:54)

The speaker claims there is 'a lot of good evidence in sauna for mitochondria.' While experimental heat therapy (such as localized diathermy or passive heating) and preclinical animal models suggest heat stress can induce mitochondrial adaptations and increase skeletal muscle mitochondrial respiratory capacity, the human evidence is very limited and in its infancy rather than abundant or definitive. Direct human trials on sauna bathing specifically measuring mitochondrial biogenesis or function are scarce, and studies on passive heating show mixed or selective outcomes (e.g., improved respiratory capacity without changes in fatty acid oxidation or citrate synthase activity).

3

Needs context

0:15:25Anurag Singhneeds contextlow

Unbiased gene expression analysis of 30,000 genes in human skeletal muscle biopsies reveals that the top 30 downregulated pathways in fatigued older adults are all mitochondrial-linked.

"you look at the 30,000 genes in the in the skeletal muscle and you ask in an unbiased way, what are the top 30 pathways that are downregulated? They are all mitochondrial-linked." (said at 0:15:25)

Transcriptomic profiling of human skeletal muscle biopsies across aging, pre-frailty, and sarcopenia consistently shows significant downregulation of mitochondrial genes and oxidative phosphorylation pathways. For example, observational microarray analyses comparing pre-frail older adults to active older adults demonstrated marked downregulation of mitochondrial gene expression alongside impaired respiratory complex activity. While bioenergetic and mitochondrial pathways are among the most prominently enriched downregulated sets in aged muscle, transcriptional remodeling in skeletal muscle aging also involves broader processes including proteostasis, inflammatory signaling, and structural components.

0:20:05Mark Hyman (host)needs contextlow

Mitochondrial function in individuals with diabetes is approximately half that of the normal population.

"when you look at mitochondrial function in diabetics, it's like half of the normal population. GUEST1: Half." (said at 0:20:05)

Classic cross-sectional biopsy studies examining skeletal muscle bioenergetics have demonstrated that electron transport chain enzyme activity (such as rotenone-sensitive NADH:O2 oxidoreductase activity) in individuals with type 2 diabetes is reduced by approximately 40% to 50% compared to lean healthy controls (e.g., 0.56 vs. 0.95 units/mU creatine kinase in Kelley et al., 2002; subsarcolemmal mitochondrial activity reduced substantially in Ritov et al., 2005). However, this reduction reflects specific ex vivo electron transport chain assays in small observational biopsy cohorts rather than an overall 50% loss of total in vivo whole-body mitochondrial function across all tissues or all diabetic individuals, where differences often reflect lower mitochondrial volume density/content, physical inactivity, and obesity rather than an intrinsic 50% global deficit.

0:31:43Anurag Singhneeds contextmoderate

Human muscle performance peaks around the third decade of life, after which people lose approximately 10% of muscle strength and mass every 10 years, with loss accelerating beyond 10% per decade in their 60s.

"So when we are in our 30s, we peak in our muscle performance around the third decade of life, and following that, every 10 years we're losing 10% of muscle strength and muscle mass, okay? And that accelerates even bigger than 10% in our 60s." (said at 0:31:43)

The speaker's general trajectory is broadly accurate but conflates the rates of loss between muscle mass and muscle strength/power. Muscle mass and performance typically peak around the third decade of life. However, skeletal muscle mass declines at a slower rate after age 30 (typically estimated at 3% to 8% per decade, or roughly ~15% total between the third and eighth decades in sedentary adults), whereas muscle strength and power decline at higher rates of approximately 10% to 15% per decade. Longitudinal studies confirm that strength loss accelerates further in older age (past age 60–70).

28

Supported by research

0:00:10Anurag Singhsupportedmoderate

Placebo-controlled randomized trials show that supplementation with a bacterial-derived postbiotic yields a 10% to 12% improvement in strength and an approximate 10% improvement in VO2 levels in the absence of exercise or dietary changes.

"Mostly the trials we have run in placebo-controlled randomized trials, we see in the absence of exercise, in the absence of changing their diets, you get about a 10-12% improvement in strength, you get about a 10% improvement in VO2 levels." (said at 0:00:10)

A placebo-controlled randomized trial in middle-aged adults evaluating daily supplementation with Urolithin A (a gut bacterial-derived postbiotic) without concomitant exercise or dietary intervention demonstrated a ~12% increase in muscle strength and significant improvements in aerobic endurance measured as peak oxygen consumption (VO2 peak). While these findings directly support the speaker's statement, certainty is moderate because the evidence comes from limited RCTs in specific populations.

0:10:05Mark Hyman (host)supportedmoderate

VO2 max has a direct linear relationship with longevity and serves as one of the strongest predictors of lifespan.

"What we do know is that VO2 max, which is basically how much oxygen you consume per minute per per kilogram of body weight, is one of the best predictors of longevity. It's in a linear way. The higher the number, I mean, the more fit you are, the more your mitochondria can, you know, consume oxygen and produce energy, the longer you're going to live." (said at 0:10:05)

Extensive observational cohort evidence and meta-analyses support the statement that cardiorespiratory fitness (quantified via VO2 max or exercise capacity in METs) is one of the strongest predictors of all-cause mortality and longevity. A 2024 umbrella review of 199 cohort studies (20.9 million observations) and a dose-response meta-analysis demonstrated a continuous, inverse dose-response relationship between cardiorespiratory fitness and all-cause mortality, where each 1-MET increment in fitness is associated with an 11% to 17% reduction in mortality risk. Furthermore, a large cohort study of 122,007 patients found no observed upper threshold of benefit, with elite performers exhibiting the lowest risk of death compared to all other performance tiers.

0:11:17Mark Hyman (host)supportedmoderate

Autism spectrum disorder is driven in part by mitochondrial dysfunction and a cerebral energy deficit.

"autism, you know, is found to have been really in part driven by mitochondrial dysfunction in these kids. They have a brain energy deficit, and Suzanne Goh showed this, who's a Harvard, Oxford-trained pediatric neurologist." (said at 0:11:17)

Published neuroimaging and biomarker studies confirm that mitochondrial dysfunction and associated energetic deficits affect a subset of individuals with autism spectrum disorder (ASD). Research led by Dr. Suzanne Goh using brain magnetic resonance spectroscopic imaging demonstrated elevated brain lactate (a biomarker of mitochondrial impairment and altered energy metabolism) in a distinct subgroup of ASD individuals compared to controls. Subsequent systematic reviews and meta-analyses corroborate that mitochondrial abnormalities, altered energetic metabolites, and elevated lactate levels are prevalent in a subgroup (approximately 15–30%) of individuals with ASD.

0:14:23Anurag Singhsupportedhigh

Mitochondrial DNA leaking into circulation from damaged mitochondria stimulates inflammatory pathways.

"Really, these damaged mitochondria that become leaky, and the damaged mitochondrial DNA—I mean, mitochondria have their own DNA that leaks out into the circulation and causes, you know, inflammation." (said at 0:14:23)

The speaker's statement accurately reflects a well-established biological mechanism. Mitochondria possess their own circular DNA (mtDNA). When mitochondrial integrity is compromised through damage, stress, or cell death, mtDNA can leak into the cytosol, extracellular space, and systemic circulation. Because of its evolutionary similarity to bacterial DNA (such as unmethylated CpG motifs), circulating cell-free mtDNA acts as a damage-associated molecular pattern (DAMP). It is recognized by innate immune sensors including Toll-like receptor 9 (TLR9), the cGAS-STING pathway, and the NLRP3 inflammasome, triggering the production and release of pro-inflammatory cytokines and driving systemic inflammation.

0:22:06Anurag Singhsupportedvery low

Exposing muscle cells or other cell types to sodium fluoride causes cellular stress in mitochondria.

"We see that actually if you put some sodium fluoride on muscle cells or any kind of cells, the mitochondria get stressed." (said at 0:22:06)

In vitro and animal experimental models demonstrate that exposure to sodium fluoride induces mitochondrial stress and dysfunction across various cell types. Experimental studies measuring mitochondrial bioenergetics show that sodium fluoride exposure triggers excessive mitochondrial reactive oxygen species (ROS) production, disrupts mitochondrial membrane potential, causes mitochondrial calcium overload, and impairs basal and maximal mitochondrial respiration and ATP production.

0:17:08Anurag Singhsupportedhigh

Exercise activates the PGC-1alpha pathway to stimulate mitochondrial biogenesis and the production of new mitochondria.

"this is the whole PGC-1alpha pathway where, you know, where you stimulate this mitochondrial biogenesis, you can improve the growth of new mitochondria." (said at 0:17:08)

The speaker's statement accurately describes a foundational principle of exercise physiology and molecular metabolism. Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) is activated in skeletal muscle by exercise (via upstream energy-sensing pathways like AMPK and SIRT1) and coordinates the downstream transcription of nuclear and mitochondrial genes required for mitochondrial biogenesis and mitochondrial network remodeling.

0:17:39Anurag Singhsupportedmoderate

Metformin, resveratrol, and NAD boosters promote mitochondrial biogenesis by targeting the AMPK pathway.

"you have these NAD boosters, compounds like resveratrol, at least from a nutrition perspective, or metformin, they're all hitting this sort of AMPK mitochondrial biogenesis pathway." (said at 0:17:39)

Metformin, resveratrol, and NAD-enhancing strategies are well-documented to converge on the interconnected AMPK/SIRT1/PGC-1α signaling network that orchestrates mitochondrial biogenesis. AMPK activation stimulates NAD+ production and SIRT1 deacetylation of PGC-1α, a master transcriptional coactivator of mitochondrial biogenesis, establishing a core positive feedback loop across metabolic regulation.

0:23:58Mark Hyman (host)supportedhigh

The human gut microbiome contains approximately two million genes, about one hundred times more genetic material than the roughly 20,000 human genes.

"And you have probably a hundred times as much bacterial DNA as your own DNA, because you've got a thousand species, they're all different, they all have different DNA. You know, we might have 20,000 genes; there might be two million bacterial genes." (said at 0:23:58)

Metagenomic sequencing of the human gut microbiome has identified millions of non-redundant microbial genes—initially catalogued at approximately 3.3 million genes across 124 individuals, which is roughly 150 times larger than the ~20,000 to 25,000 protein-coding genes in the human genome. The speaker's approximation of around 2 million bacterial genes (about 100 times more than the roughly 20,000 human genes across ~1,000 species) accurately reflects this established scientific finding.

  • supports: A human gut microbial gene catalogue established by metagenomic sequencing. (Nature 2010) · cited 11824x in the literature
    "Here we describe the Illumina-based metagenomic sequencing, assembly and characterization of 3.3 million non-redundant microbial genes, derived from 576.7 gigabases of sequence, from faecal samples of 124 European individuals. The gene set, approximately 150 times larger than the human gene complement, contains an overwhelming majority of the prevalent (more frequent) microbial genes of the cohort and probably includes a large proportion of the prevalent human intestinal microbial genes." (abstract, passage verified)
    pubmedfull study (doi)
0:33:46Mark Hyman (host)supportedhigh

The Recommended Dietary Allowance (RDA) for protein is 0.8 grams per kilogram of body weight.

"Because the RDA is 0.8 grams per kilo, which is the minimum you need to prevent a deficiency of protein, but not maximum amount you need for optimal health." (said at 0:33:46)

The Recommended Dietary Allowance (RDA) for dietary protein in adults is established at 0.8 grams per kilogram of body weight per day. Established via nitrogen balance studies, the RDA represents the minimum daily intake necessary to prevent deficiency and avoid a net loss of body protein, rather than the level required for optimal health or muscle maintenance.

0:34:59Mark Hyman (host)supportedhigh

Animal protein sources provide higher levels of leucine, the amino acid necessary to stimulate muscle protein synthesis, compared to plant protein sources.

"But if you use animal protein, you're going to get a much more concentrated protein at a lower calorie count and also with higher levels of leucine, which is the amino acid you need to actually make muscle." (said at 0:34:59)

Animal protein sources generally provide higher protein density per calorie and higher concentrations of essential amino acids, particularly leucine, compared to most plant-based protein sources. Leucine is well established as the key trigger for activating the mTOR pathway to stimulate muscle protein synthesis (MPS). While certain isolated or blended plant proteins (e.g., corn isolate or leucine-fortified blends) can match the leucine threshold, typical whole-food plant proteins have lower leucine concentrations, lower digestibility, and less concentrated protein per caloric intake than animal proteins.

0:40:09Anurag Singhsupportedmoderate

Urolithin A is a metabolite produced by the gut microbiome from dietary polyphenols and ellagitannins found in foods like pomegranates.

"So what we discovered was that this molecule, urolithin A, is actually not a waste product. It's actually a very potent gut metabolite produced by the gut microbiome that has these immense rejuvenation effects on mitochondria." (said at 0:40:09)

Published research confirms that urolithin A is a postbiotic gut microbial metabolite synthesized by the gut microbiota from dietary precursors, specifically ellagitannins and ellagic acid found in foods such as pomegranates, nuts, and berries. Preclinical and human clinical studies demonstrate that urolithin A stimulates mitophagy (the selective degradation and recycling of damaged mitochondria) and mitochondrial biogenesis, which enhances mitochondrial function and muscle endurance.

0:41:30Anurag Singhsupportedhigh

Placebo-controlled randomized trials show that urolithin A supplementation leads to approximately a 10% to 12% improvement in muscle strength, a 10% increase in VO2 levels, and lower inflammation without changes in exercise or diet.

"Mostly the trials we've run in in placebo-controlled randomized trials, we see in the absence of exercise, in the absence of changing their diets, you get about a 10, 12% improvement in strength, you get about a 10% improvement in VO2 levels. So this aerobic endurance we talked about, and you also get lower inflammation." (said at 0:41:30)

Randomized, placebo-controlled clinical trials support the claim. In middle-aged adults (40–65 years old), four months of daily Urolithin A (Mitopure) supplementation without exercise or dietary changes led to a statistically significant ~12% improvement in muscle strength, improvements in aerobic endurance/peak VO2, and significant reductions in C-reactive protein (CRP), indicating reduced systemic inflammation. Similar reductions in inflammatory markers (CRP) and improvements in muscle endurance were also demonstrated in a separate 4-month randomized controlled trial in older adults.

0:47:42Anurag Singhsupportedmoderate

A clinical trial administering urolithin A for one month to healthy 40- to 50-year-olds profiling over 80 immune populations showed an increase in age-declining immune cells (such as T cells and NK cells) containing higher numbers of mitochondria and enhanced pathogen-killing capacity.

"And he said, 'Well, let's do a trial where we give this molecule for a month to healthy 40, 50-year-olds and we look at every single immune cell in the body, at the impact it's causing and the mitochondria in it.'... What we actually now find with supplementation is that a lot of these immune cells that are declining with aging, they come back with Mitopure supplementation. And when they come back, they have more mitochondria... And these immune cells are more wired to fight infection. So if you throw an infection on them, they engulf it and kill it much faster." (said at 0:47:42)

A double-blind, randomized, placebo-controlled clinical trial in 50 healthy middle-aged adults evaluated 4 weeks (1 month) of oral urolithin A (1,000 mg/day) supplementation. The trial found that urolithin A supplementation expanded naive-like CD8+ T cells and peripheral NK cell subsets, augmented mitochondrial biogenesis in CD8+ T cells, improved T-cell cytokine activation, and enhanced bacterial phagocytosis (uptake) in monocytes.

0:30:44Anurag Singhsupportedhigh

High-intensity training and aerobic training have a greater impact on improving mitochondrial health than resistance training.

"Resistance training less so as something like high-intensity training or aerobic training in terms of the impact on mitochondrial health." (said at 0:30:44)

The speaker's claim is supported by exercise physiology literature. Aerobic training and high-intensity interval training are well-established primary stimuli for mitochondrial biogenesis, oxidative enzyme activity, and mitochondrial respiratory capacity in skeletal muscle, primarily through activation of the AMPK-PGC-1α signaling cascade. While resistance training can induce modest mitochondrial improvements (particularly under high-volume or low-load paradigms), its primary adaptive priority and physiological signaling pathways (such as mTORC1) drive myofibrillar protein synthesis, muscle hypertrophy, and ribosome biogenesis rather than substantial mitochondrial remodeling.

1:25:29Mark Hyman (host)supportedhigh

Metformin inhibits mitochondrial complex I, which interferes with mitochondrial function.

"one of the consequences of metformin is that it inhibits mitochondrial complex I, which while it seems like it helps with blood sugar and many things you'd want to have it help with, it also interferes with mitochondrial function" (said at 1:25:29)

A primary and well-established mechanism of action of metformin is the mild inhibition of mitochondrial complex I (NADH:ubiquinone oxidoreductase) of the electron transport chain. This inhibition disrupts standard mitochondrial respiratory chain function, altering the cellular AMP-to-ATP ratio, activating AMP-activated protein kinase (AMPK), reducing hepatic gluconeogenesis, and enhancing intestinal glucose uptake, thereby lowering blood glucose levels.

1:29:16Anurag Singhsupportedvery low

In animal models of heart failure, Mitopure (Urolithin A) supplementation reversed cardiac damage by improving mitochondrial health.

"we went into models of heart failure, acute and chronic, and we found that giving Mitopure supplementation in these models reversed a lot of this cardiac damage by improving mitochondrial health." (said at 1:29:16)

Preclinical studies in animal models of heart failure and cardiac aging support the claim. Research shows that Urolithin A (Mitopure) supplementation reduces cardiac dysfunction, hypertrophy, and fibrosis while restoring mitochondrial ultrastructure, respiration, and mitophagy. Because these findings are established in animal and cellular models, the certainty of evidence for clinical human efficacy in heart failure remains very low.

1:30:00Anurag Singhsupportedmoderate

In clinical trials, Mitopure supplementation reduces plasma levels of ceramides in humans.

"And what we see is actually in all our trials, plasma levels of ceramides are going down." (said at 1:30:00)

Randomized controlled trials evaluating urolithin A (Mitopure) supplementation in older adults have demonstrated reductions in circulating plasma ceramide levels. In a double-blind, placebo-controlled clinical trial (PMID 35050355), four months of oral urolithin A supplementation significantly decreased plasma levels of several ceramides, acylcarnitines, and C-reactive protein compared with placebo. Subsequent analyses and human trials (PMID 40034121) similarly report that four months of urolithin A supplementation reduces cardiovascular-risk-associated plasma ceramides.

1:30:30Anurag Singhsupportedmoderate

The Mayo Clinic has a clinical ceramide score that predicts cardiovascular disease prognosis.

"there's the Mayo Clinic that has now a score of ceramides that allows you to predict the prognosis of cardiovascular health." (said at 1:30:30)

Mayo Clinic researchers developed and clinically implemented a plasma ceramide risk score (evaluating circulating ceramides such as Cer(16:0), Cer(18:0), and Cer(24:1) along with their ratios to Cer(24:0)) to assess cardiovascular risk. Prospective cohort studies have demonstrated that higher ceramide risk scores independently predict major adverse cardiovascular events (including myocardial infarction, stroke, and cardiovascular mortality) even after adjusting for standard lipid panels and traditional cardiovascular risk factors.

1:30:50Anurag Singhsupportedmoderate

Mitopure (Urolithin A) supplementation improves VO2 max in humans.

"But we do know things like VO2 max improve with Mitopure, which is also cardiovascular health." (said at 1:30:50)

A double-blind, randomized, placebo-controlled trial evaluating Urolithin A (Mitopure) supplementation in middle-aged adults demonstrated improvements in aerobic endurance measured by peak oxygen consumption (peak VO2) and 6-minute walk distance, alongside improvements in muscle strength and mitochondrial biomarkers. In trained male distance runners, supplementation also led to significant within-group increases in VO2 max, although between-group differences compared to placebo during altitude training camp did not reach statistical significance.

1:35:07Anurag Singhsupportedmoderate

Skin fibroblasts and keratinocytes accumulate mitochondrial damage with aging.

"skin cells in the fibroblasts or the keratinocytes—these are the two main cells in the epidermis and the dermis—they have lots of mitochondria. And over aging, over time of adult healthspan, they get damaged in much the same way as muscle and brain cells do." (said at 1:35:07)

Skin fibroblasts (in the dermis) and keratinocytes (in the epidermis) accumulate mitochondrial damage and dysfunction over chronological aging and photoaging. Published literature demonstrates that advancing age and cumulative environmental stressors lead to mitochondrial DNA (mtDNA) damage, impaired oxidative phosphorylation, elevated reactive oxygen species (ROS), and defective mitophagy in cutaneous cells, mirroring aging pathways observed in high-energy metabolic tissues.

1:48:38Anurag Singhsupportedmoderate

Statins deplete the electron transport chain and cause coenzyme Q10 deficiency.

"At a higher level, they are mitochondrial toxins, and they deplete the electron transport chain, and CoQ10 deficiency happens." (said at 1:48:38)

Statins inhibit HMG-CoA reductase, an upstream enzyme in the mevalonate pathway required for the biosynthesis of coenzyme Q10 (CoQ10/ubiquinone), an essential electron carrier in the mitochondrial electron transport chain. A systematic review and meta-analysis of randomized placebo-controlled trials confirmed that statin therapy significantly reduces circulating CoQ10 concentrations across all statin classes (WMD: -0.44 μmol/L, 95% CI: -0.52 to -0.37). In addition, in vitro and preclinical studies demonstrate that higher concentrations of statins exhibit mitochondrial toxicity by inhibiting electron transport chain complexes (such as Complex I and III) and impairing oxidative phosphorylation, mechanisms implicated in statin-induced myopathy.

1:50:09Mark Hyman (host)supportedhigh

The mevalonate pathway that synthesizes cholesterol also produces coenzyme Q10.

"the same pathway that makes your LDL cholesterol also makes coenzyme Q10, which is one of the mitochondrial helpers, cofactors." (said at 1:50:09)

The mevalonate pathway (initiated by HMG-CoA reductase) is responsible for the endogenous biosynthesis of cholesterol and also generates isoprenoid intermediates (such as farnesyl pyrophosphate) required for the synthesis of coenzyme Q10 (ubiquinone), an essential cofactor in the mitochondrial electron transport chain.

1:29:16Anurag Singhsupportedmoderate

Cardiac biopsies from patients who have heart failure or died of cardiac degeneration show poor mitochondrial health as a hallmark signature.

"they actually looked at cardiac biopsies of people who had heart failure or had died of heart degeneration and with the aging process. And again, the signature, the hallmark signature they picked up in the heart was poor mitochondrial health." (said at 1:29:16)

Published clinical and histopathological studies evaluating human myocardial biopsies confirm that mitochondrial abnormalities and dysfunction are hallmark signatures of cardiac degeneration, aging, and heart failure. In patients undergoing endomyocardial biopsies for heart failure, structural and functional mitochondrial impairments (such as cristae disorganization and membrane disruption) are prominent features that correlate strongly with disease severity, impaired reverse remodeling, and adverse cardiovascular outcomes.

1:36:00Anurag Singhsupportedhigh

Matrix metalloproteinases (MMPs) degrade collagen and increase significantly with aging.

"And there are enzymes called matrix metalloproteinases, MMPs, that degrade collagen that just shoot up with aging." (said at 1:36:00)

Matrix metalloproteinases (MMPs), particularly collagenases such as MMP-1, are enzymes responsible for degrading collagen fibrils in human extracellular matrix. Extensive human skin tissue and cell culture studies confirm that MMP expression and activity increase significantly with chronological aging and photoaging, driving age-related collagen fragmentation and loss.

1:50:29Anurag Singhsupportedhigh

Coenzyme Q10 has low oral bioavailability.

"CoQ10 is not also a very highly bioavailable compound when taken orally." (said at 1:50:29)

Coenzyme Q10 (CoQ10 / ubiquinone) is well established in pharmacokinetic research to possess poor oral bioavailability. Due to its high molecular weight (863 g/mol), strong lipophilicity/hydrophobicity, and poor aqueous solubility, intestinal absorption of standard oral CoQ10 is slow and limited, prompting extensive pharmaceutical development into specialized delivery systems (such as solubilized, lipid-based, or nanoemulsion formulations) to improve systemic absorption.

1:57:11Anurag Singhsupportedmoderate

Vitamin D has beneficial effects on mitochondrial function and immune cells.

"You know, vitamin D—we didn't talk about that, but also has some great effects on mitochondria and immune cells." (said at 1:57:11)

Published molecular, preclinical, and human experimental studies demonstrate that vitamin D and its active metabolite calcitriol (1,25-dihydroxyvitamin D) exert significant regulatory and protective effects on both mitochondrial function and immune cells. Vitamin D influences mitochondrial energy production, dynamics (fission-fusion), and membrane potential while modulating innate and adaptive immune cell signaling, metabolic reprogramming, and cytokine production.

1:56:42Mark Hyman (host)supportedhigh

Mitochondria originated evolutionarily from bacteria and possess distinct DNA inherited maternally.

"mitochondria historically came from bacteria. So they're basically a symbiotic relationship with bacteria and humans, and they're not the same in terms of their DNA. They're actually quite different than your DNA. They come from your mother, but it's mitochondrial DNA." (said at 1:56:42)

The speaker's statement accurately reflects fundamental biological principles established by extensive evolutionary and genetic evidence. Mitochondria originated through endosymbiosis from ancestral α-proteobacteria, establishing a symbiotic relationship within eukaryotic cells. Mitochondria maintain their own distinct genome (mitochondrial DNA, or mtDNA), which is separate from nuclear chromosomal DNA and is strictly inherited through maternal lineage in humans.

1:57:42Anurag Singhsupportedmoderate

Studies demonstrate that antibiotics act as mitochondrial stressors.

"There's enough studies showing they're mitochondrial stressors. Now, I think it really depends on the duration of usage, the dose, and certain classes of antibiotics are probably worse off than the others." (said at 1:57:42)

The statement that studies demonstrate antibiotics act as mitochondrial stressors—with effects depending on duration, dose, and antibiotic class—is supported by published literature. Due to the shared evolutionary origin between mitochondria and bacteria, several major classes of antibiotics (such as aminoglycosides, fluoroquinolones, macrolides, and oxazolidinones like linezolid) can inhibit mitochondrial protein synthesis or electron transport chain activity. A landmark study demonstrated that clinically relevant concentrations of bactericidal antibiotics (quinolones, aminoglycosides, and beta-lactams) induce mitochondrial dysfunction, overproduction of reactive oxygen species (ROS), and oxidative damage in mammalian cells and animal models. Furthermore, clinical investigations in humans show that prolonged exposure to specific agents, such as linezolid, induces progressive mitochondrial respiratory impairment in a duration-dependent manner.

5

No source found (not proven false)

0:08:52Anurag Singhunverifiedvery low

A human brain neuron contains approximately 17,000 mitochondria, and a skeletal muscle cell contains 10,000 to 15,000 mitochondria.

"I think it's like, what is it, 17,000 of these in every brain cell? GUEST1: In every, and close to 10-15,000 in a skeletal muscle cell." (said at 0:08:52)

No published record matching the claim that a human brain cell contains approximately 17,000 mitochondria and a skeletal muscle cell contains 10,000 to 15,000 mitochondria was located; this does not prove the claim false. While neurons and skeletal muscle cells have high metabolic demands and substantial mitochondrial content, mitochondrial morphology exists largely as dynamic reticular networks rather than uniform, discrete counts across cell types.

0:23:58Mark Hyman (host)unverifiedvery low

Between one-third and one-half of all metabolites circulating in human blood are derived from the gut microbiome.

"Stan Hazen said that a third to half of all the metabolites in your blood come from your microbiome." (said at 0:23:58)

No published record matching the specific claim that between one-third and one-half of all metabolites in human blood originate from the gut microbiome (attributed to Dr. Stanley Hazen) was located; this does not prove the claim false.

0:40:27Anurag Singhunverifiedvery low

Approximately 40% of sampled French and Italian individuals naturally produce detectable urolithin A from their diet, compared to 10% in the US and Canada and 5% in India.

"So if you go to the French and the Italians, you find out of 100 people you sample, 40% will make from the diet naturally, real-world level, they will have some levels of urolithin A in their bloodstream. You go to the US and Canada, that number drops to 10%... You go to my origin country, which is India, where every kid growing up in their first year is given antibiotics for everything, the incidence drops to 5%." (said at 0:40:27)

No published record matching the claim that approximately 40% of French and Italian individuals, 10% of individuals in the US and Canada, and 5% of individuals in India naturally produce detectable urolithin A from their diet was located; this does not prove the claim false. While human nutritional studies show that the gut microbiota's ability to metabolize dietary ellagitannins into urolithins varies substantially between individuals (with general producer phenotypes typically estimated at 30% to 40% in healthy cohorts), standardized multi-country epidemiological datasets validating these specific geographic percentages and attributing the lower rate in India to early-life antibiotic use have not been published.

1:35:45Anurag Singhunverifiedvery low

In randomized trials, topical Mitopure improved mitochondrial health in skin biopsies and decreased levels of collagen-degrading matrix metalloproteinases (MMPs).

"we made these topical formulations with Mitopure and applied it in randomized trials in middle-aged, older-age volunteers. And lo and behold, when we did the skin biopsies, the mitochondrial health started turning... And what we saw in these trials was that MMP levels were going down." (said at 1:35:45)

No published record matching randomized clinical trials of topical Mitopure (urolithin A) assessing mitochondrial health and matrix metalloproteinase (MMP) levels in human skin biopsies was located; this does not prove the claim false. While in vitro laboratory studies in cultured human dermal fibroblasts have demonstrated that urolithin A can induce mitophagy and downregulate MMP-1 expression, peer-reviewed human randomized trial data evaluating topical formulations and skin biopsy outcomes remain unpublished in the medical literature.

1:58:47Anurag Singhunverifiedvery low

Research shows that living in colder environments is better for mitochondrial function than living in warmer or tropical climates.

"There's a great research coming out from one of our collaborators who co-discovered Urolithin with us, where he's seeing that living in cold rooms or colder areas is better for your mitochondria than living in hot climates and tropical areas." (said at 1:58:47)

No published record matching the claim that living in colder environments or rooms is better for mitochondrial function than living in warmer or tropical climates was located; this does not prove the claim false. While acute cold exposure is known to stimulate brown adipose tissue thermogenesis and mitochondrial uncoupling in laboratory models, broad epidemiological or comparative physiological trials establishing superior mitochondrial function from residing in cold versus tropical climates have not been published.

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.